by Aaron Yang | Nov, 2022 | General
What is synthetic data and why is it important? There is no turning back the clock on the power, impact and future ubiquity of machine learning algorithms – which is why it’s an active investment area at AV8 Ventures. However, ML has several challenges that must...
by Ruchita Sinha | Aug, 2022 | General
We are excited to announce our latest investment in Think Bioscience. Think falls squarely in the middle of AV8’s life science investment thesis to invest in novel platforms that combine computational approaches with a strong understanding of biology. Think Bioscience...
by Amir Kabir | Mar, 2022 | General
The insurance industry is one of the oldest industries in the world with an estimated global market size of $10.00Tn by 2030. Looking at the history of insurance, many would say that the UK is regarded to be the birthplace of modern insurance, dating back to the 18th...
by Ruchita Sinha | Sep, 2021 | General
AV8 is no stranger to Myong Lee and Clever Care. We have been tracking the company ever since they raised their Series A in 2020. As any healthcare investor likely knows, Medicare Advantage (MA) is a $300B+ market that has more than doubled over the past decade. In...
by Baris Aksoy | Sep, 2021 | General
We have been a big fan of Jack Vines, CEO/founder of Measured Analytics and Insurance (AI) since I met him at an event showcasing startups in Utah. As Jack was building the team and the early product, we kept in touch. We were impressed with his thoughtful approach to...
by AV8 Ventures | Sep, 2021 | General
Today we are thrilled to announce the launch of AV8 Ventures II, a $180mil fund backed by Allianz SE. Our mission continues to be partnering with exceptional entrepreneurs as one of their earliest investors. We back start-ups in four areas: modernizing enterprises by...
Recent Comments